Insider at

04

Insider transactions

05
0 buys (P) 2 sells (S) Net: $-195,960 + 10 non-open-market transactions below 12 months to the week close of 2026-10-23

Price change vs the latest weekly close (updated to the current quote in your browser when available), split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

10 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Feb. 17, 2026 AURA S 20,401 $5.06 $103,229 232,284 Direct -8.07% Disposed 24.5% (price as of )
Nov. 17, 2025 AURA S 17,109 $5.42 $92,731 252,685 Direct -6.34% Disposed 16.2% (price as of )
Feb. 18, 2025 AURA S 2,534 $7.75 $19,638 269,794 Direct -0.93% Disposed -18.7% (price as of )
Nov. 18, 2024 AURA S 11,822 $9.36 $110,654 151,693 Direct -7.23% Disposed -32.7% (price as of )

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Sept. 1, 2026 AURA Stock Option (Right to Buy) Common Stock (116,150) $7.43 Sept. 1, 2036 116,150 Acquired
March 2, 2026 AURA Stock Option (Right to Buy) Common Stock (160,944) $6.14 March 2, 2036 160,944 Acquired
Feb. 3, 2025 AURA Stock Option (Right to Buy) Common Stock (79,365) $7.68 Feb. 2, 2035 79,365 Acquired
Feb. 1, 2024 AURA Stock Option (Right to Buy) Common Stock (41,485) $7.77 Jan. 31, 2034 41,485 Acquired
Nov. 1, 2023 AURA Stock Option (Right to Buy) Common Stock (200,000) $8.97 Oct. 31, 2033 200,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

10

Matched by name from proxy statements (DEF 14A) — verify against the filing.

AURA

M.D.Chief Medical Officer and President of Research and Development
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2025 $551,250 · · · $220,500 · $21,000 $2,188,965
2024 $525,000 · · · $236,250 · · $1,226,076
2023 $109,375 $200,000 · · $49,536 · · $2,935,681

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.